Literature DB >> 2446320

Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).

W I Sundquist1, S J Lippard, B D Stollar.   

Abstract

Murine monoclonal antibodies that bind selectively to adducts formed on DNA by the antitumor drug cis-diamminedichloroplatinum(II), cis-DDP, or to the chemotherapeutically inactive trans isomer trans-DDP were elicited by immunization with calf thymus DNA modified with either cis- or trans-DDP at ratios of bound platinum per nucleotide, (D/N)b, of 0.06-0.08. The binding of two monoclonal antibodies to cis-DDP-modified DNA was competitively inhibited (50% control) in an enzyme-linked immunosorbent assay (ELISA) by 4-6 nM concentrations (600-900 fmol) of cis-DDP bound to DNA, (D/N)b = 0.031. Similar concentrations (4-6 nM) of cis-DDP-modified poly(dG).poly(dC) also inhibited antibody binding, whereas higher concentrations (17-36 nM) of cis-DDP-modified poly[d(AG)].poly[d(TC)] were required for inhibition. Adducts formed by cis-DDP on other synthetic DNA polymers did not inhibit antibody binding to cis-DDP-DNA. The biologically active compounds [Pt(en)Cl2], [Pt(dach)Cl2], and [Pt(NH3)2(cbdca)] (carboplatin) (where en is ethylenediamine, dach is 1,2-diaminocyclohexane, and cbdca is cyclobutane-1,1-dicarboxylate) all formed antibody-detectable adducts on DNA, whereas the inactive platinum complexes trans-DDP and [Pt(dien)Cl]Cl (dien, diethylenetriamine) did not. The monoclonal antibodies therefore recognize a bifunctional Pt-DNA adduct with cis stereochemistry in which platinum is coordinated by two adjacent guanines or, to a lesser degree, by adjacent adenine and guanine. A monoclonal antibody raised against trans-DDP-DNA was competitively inhibited in an ELISA by 40 nM trans-DDP bound to DNA, (D/N)b = 0.022. This antibody crossreacted with unmodified, denatured DNA. Its binding to trans-DDP-DNA was selectively inhibited by trans-DDP-modified poly[d(GT)].poly[d(CA)] (50% inhibition at 1 nM bound trans-DDP). The recognition of cis- or trans-DDP-modified DNAs by monoclonal antibodies thus parallels the known modes of DNA binding of these compounds and may correlate with their biological activities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446320      PMCID: PMC299514          DOI: 10.1073/pnas.84.23.8225

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Physicochemical studies on polydeoxyribonucleotides containing defined repeating nucleotide sequences.

Authors:  R D Wells; J E Larson; R C Grant; B E Shortle; C R Cantor
Journal:  J Mol Biol       Date:  1970-12-28       Impact factor: 5.469

Review 2.  Immunoassay of carcinogen-modified DNA.

Authors:  P T Strickland; J M Boyle
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

3.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 4.  Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

Authors:  A L Pinto; S J Lippard
Journal:  Biochim Biophys Acta       Date:  1985

5.  Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).

Authors:  A L Pinto; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.

Authors:  M C Poirier; S J Lippard; L A Zwelling; H M Ushay; D Kerrigan; C C Thill; R M Santella; D Grunberger; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.

Authors:  B Malfoy; B Hartmann; J P Macquet; M Leng
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

8.  Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

Authors:  A M Fichtinger-Schepman; J L van der Veer; J H den Hartog; P H Lohman; J Reedijk
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

9.  The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.

Authors:  A C Plooy; A M Fichtinger-Schepman; H H Schutte; M van Dijk; P H Lohman
Journal:  Carcinogenesis       Date:  1985-04       Impact factor: 4.944

10.  Comparison between poly(dG-dC).poly(dG-dC) and DNA modified by cis-diamminedichloroplatinum (II): immunological and spectroscopic studies.

Authors:  A Rahmouni; J M Malinge; A Schwartz; M Leng
Journal:  J Biomol Struct Dyn       Date:  1985-10
View more
  8 in total

Review 1.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

2.  Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA.

Authors:  J M Malinge; C Pérez; M Leng
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

3.  Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.

Authors:  P M Terheggen; B G Floot; E L Lempers; O van Tellingen; A C Begg; L den Engelse
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

Review 5.  Genomic approaches to DNA repair and mutagenesis.

Authors:  John J Wyrick; Steven A Roberts
Journal:  DNA Repair (Amst)       Date:  2015-09-15

6.  Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.

Authors:  Bernd Liedert; Dick Pluim; Jan Schellens; Jürgen Thomale
Journal:  Nucleic Acids Res       Date:  2006-03-29       Impact factor: 16.971

7.  Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.

Authors:  C Meijer; E G de Vries; W A Dam; M H Wilkinson; H Hollema; H J Hoekstra; N H Mulder
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancer.

Authors:  G Balconi; Y Pang; M Broggini; F Morali; M Marzola; E Erba; M Ponti; L Spinelli; C Mangioni; L Redaelli
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.